Global glucose-metabolizing systems

Global glucose-metabolizing systems encompass the complex, multi-organ network responsible for maintaining blood glucose levels within a narrow physiological range (StatPearls, 2023). This system integrates the metabolic activities of the liver, pancreas, skeletal muscle, and adipose tissue, primarily regulated by the opposing actions of insulin and glucagon (NIH, 2022). Key biochemical pathways involved include glycolysis for energy production, gluconeogenesis for endogenous glucose synthesis, and glycogenesis for energy storage (PubMed, 2021). Dysregulation of these systems is the primary driver of metabolic disorders such as Type 2 Diabetes Mellitus, where insulin resistance leads to chronic hyperglycemia and systemic complications (WHO, 2023). While the term does not describe a single molecular target, it serves as the functional umbrella for numerous therapeutic interventions (PubChem, 2024). Drugs like metformin, SGLT2 inhibitors, and GLP-1 receptor agonists target specific enzymes or receptors within this system to restore metabolic balance. Consequently, understanding the global system is essential for developing multi-target or systemic approaches to metabolic disease management.

Other names

Glucose metabolismCarbohydrate metabolismGlycemic control pathwaysGlucose homeostasis system

Modulation of this system occurs through various mechanisms including insulin receptor agonism, inhibition of hepatic gluconeogenesis, enhancement of insulin secretion, and blockade of renal glucose reabsorption.